Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Flynn

Showing results (871-880 of 1,011) with videos related to

Pageof 102
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 12, 2018
Diglycolic acid induces HepG2/C3A liver cell toxicity in vitroMiriam E Mossoba, Sanah Vohra, Howard Toomer, et al.
The Journal of Eukaryotic Microbiology|February 27, 2023
The Mixoplankton Database (MDB): Diversity of photo-phago-trophic plankton in form, function, and distribution across the global oceanAditee Mitra, David A Caron, Emile Faure, et al.
Leukemia|February 25, 2015
Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemiaJ Flynn, J Jones, A J Johnson, et al.
Cancer|December 15, 1980
Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2004
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancerAl B Benson, Deborah Schrag, Mark R Somerfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiformeV A Levin, J H Uhm, K A Jaeckle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trialEvanthia Galanis, S Keith Anderson, Jackie M Lafky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 2, 2008
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B)Aminah Jatoi, Shaker R Dakhil, Nathan R Foster, et al.
Vaccine|September 18, 2010
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primatesKavita Tewari, Barbara J Flynn, Silvia B Boscardin, et al.
Journal of Palliative Medicine|October 22, 2005
Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxineCharles L Loprinzi, Patrick J Flynn, Lisa A Carpenter, et al.
Pageof 102

Showing results (871-880 of 1,011) with videos related to

Sort By:
Pageof 102
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 12, 2018
Diglycolic acid induces HepG2/C3A liver cell toxicity in vitroMiriam E Mossoba, Sanah Vohra, Howard Toomer, et al.
The Journal of Eukaryotic Microbiology|February 27, 2023
The Mixoplankton Database (MDB): Diversity of photo-phago-trophic plankton in form, function, and distribution across the global oceanAditee Mitra, David A Caron, Emile Faure, et al.
Leukemia|February 25, 2015
Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemiaJ Flynn, J Jones, A J Johnson, et al.
Cancer|December 15, 1980
Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trialC A Hubay, O H Pearson, J S Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2004
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancerAl B Benson, Deborah Schrag, Mark R Somerfield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiformeV A Levin, J H Uhm, K A Jaeckle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trialEvanthia Galanis, S Keith Anderson, Jackie M Lafky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 2, 2008
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B)Aminah Jatoi, Shaker R Dakhil, Nathan R Foster, et al.
Vaccine|September 18, 2010
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primatesKavita Tewari, Barbara J Flynn, Silvia B Boscardin, et al.
Journal of Palliative Medicine|October 22, 2005
Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxineCharles L Loprinzi, Patrick J Flynn, Lisa A Carpenter, et al.
Pageof 102